The landscape of dementia analysis has evolved significantly with the appearance of refined biomarkers, which include amyloid PET scans, tau imaging, and blood-based exams which will detect Alzheimer's pathology decades prior to indicators arise. When these technological innovations represent outstanding progress in comprehension neurodegenerative